Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) FCF Margin (2017 - 2025)

Historic FCF Margin for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to 373.08%.

  • Arcus Biosciences' FCF Margin fell 4251600.0% to 373.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 193.33%, marking a year-over-year decrease of 1290700.0%. This contributed to the annual value of 68.22% for FY2024, which is 2138300.0% up from last year.
  • As of Q3 2025, Arcus Biosciences' FCF Margin stood at 373.08%, which was down 4251600.0% from 83.12% recorded in Q2 2025.
  • In the past 5 years, Arcus Biosciences' FCF Margin ranged from a high of 3616.67% in Q1 2022 and a low of 846.3% during Q2 2021
  • In the last 5 years, Arcus Biosciences' FCF Margin had a median value of 244.44% in 2022 and averaged 105.5%.
  • Its FCF Margin has fluctuated over the past 5 years, first skyrocketed by 43560900bps in 2022, then plummeted by -40246700bps in 2023.
  • Over the past 5 years, Arcus Biosciences' FCF Margin (Quarter) stood at 19.84% in 2021, then tumbled by -938bps to 205.88% in 2022, then tumbled by -47bps to 303.23% in 2023, then fell by -28bps to 388.46% in 2024, then grew by 4bps to 373.08% in 2025.
  • Its FCF Margin was 373.08% in Q3 2025, compared to 83.12% in Q2 2025 and 475.0% in Q1 2025.